Juliane Glaeser, PhD, is a cell and molecular biologist with an extensive background in musculoskeletal research, as well as mesenchymal stem cell and matrix metalloprotease research. She has more than seven years of experience in the design, implementation and optimization of novel assays in mammalian cell culture and molecular biology, which includes the use of bioreactor systems. Glaeser identified mechanically regulated matrix metalloproteases in mesenchymal stem cells resulting in the stimulation of stem cell function and angiogenesis. She co-developed a medical device prototype for an intra-operative prediction of bone healing efficacy, which included the establishment and maintenance of a tissue bank for human fracture hematoma and testing of pro-inflammatory cytokine levels in these tissues. Just recently, she obtained a certificate in Clinical Trials: Medical Device and Drug Development at University of California, Irvine.